Eupraxia Pharmaceuticals' First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week

mental-health

Eupraxia Pharmaceuticals' First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week

ONLY AVAILABLE IN PAID PLANS.

Originally reported by benzinga. Read more

Source: https://www.benzinga.com/pressreleases/26/05/g52315302/eupraxia-pharmaceuticals-first-release-of-eoehss-sub-scores-data-from-its-ongoing-phase-1b2a-resol